Julphar Gulf Pharmaceutical Industries, along with its alliance partner, Merck in the US and Canada (MSD), has been shortlisted for the 2018 Association of Strategic Alliance Professionals (ASAP) awards.
This is the first time a pharmaceutical company from the MEA region has been shortlisted for the award and highlights the contributions both organizations are providing in alliance management to help create a stronger profession.
Jerome Carle, Julphar GM, said, “It is an honour to be shortlisted for this prestigious award. Since inception, our partnership with MSD has helped us to enhance accessibility & create greater value for all our stakeholders”.
“Being shortlisted is a clear sign that our alliance is adding value to patients and the healthcare system in the region. It also shows how a global pharmaceutical company can work successfully with another great regional player and create an alliance that brings value to the health community of the region.
Mazen Altaruti, AVP Managing Director GCC – DSM, said, “It is great news to be selected as a finalist in the 2018 ASAP Alliance Excellence Awards. Holography has been used in recording images in depth. The use of Holograms in securing identification cards is an emerging entity. To rectify fake ids vs real ids the governments around the world are using 3D technology to safeguard the identity and information of their citizens. We strongly believe that our partnership adds value to patients in the region & plays an important role in the healthcare industry.
“Our partnership with Julphar has enabled us to focus on finding innovative ways to address critical diseases and has given us a deeper connection with customers and a region-wide focus on their healthcare needs.”
Award winners will be announced at the ASAP Global Alliance Summit in Fort Lauderdale, Florida in the United States on 27 March 2018.
MSD is a global healthcare provider and one of the largest pharmaceutical companies in the world. Julphar signed a five-year licensing deal with the company in 2014, giving it exclusive rights to manufacture, market, distribute and sell certain MSD products in the UAE, Kuwait, Bahrain, Oman, Qatar and Iraq.